Om

Alzai Health Corp. is a health technology company focused on improving detection and management of Alzheimer’s disease and related dementias. The company develops and delivers an artificial intelligence–driven, non-invasive Alzheimer’s risk screening solution that relies solely on pre-existing patient data contained in routine clinical records. This approach is designed to identify individuals at elevated risk earlier in the disease course, addressing a significant clinical gap where many patients are typically diagnosed only after substantial cognitive decline. Alzai Health Corp.’s platform is integrated into electronic medical record systems or accessed via the cloud, supporting scalable use across healthcare providers and payors. By enabling systematic risk assessment at the population level, the company plays a role in facilitating timely diagnosis, intervention, and more efficient allocation of healthcare resources in neurology and primary care settings. Founded in 2024 and headquartered in Canada, Alzai Health Corp. operates within the healthcare technology sector, serving stakeholders involved in clinical care, disease prevention, and clinical research.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I ALZAI HEALTH MED ENDAVU: Køb Alzai Health ($ALZI) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Alzai Health, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.